Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions

B Cell Lymphoma

Interventions

DRUG

Rituximab -CHOP plus Velcade

Trial Locations (4)

Hôpital Lyon Sud, Pierre-Bénite

Hôpital Saint-Louis, Paris

Hôpital Henri Mondor, Créteil

Institut Gustave Roussy, Villejuif

All Listed Sponsors

collaborator

Association pour le Développement de la Recherche Clinique et Informatique en Onco-Hématologie

OTHER

lead

Lymphoma Study Association

OTHER

NCT00169468 - Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma | Biotech Hunter | Biotech Hunter